Evidence map›Paper›PMID 31824471›Full record

ArticleFrontiers in microbiology2019

A Continuous-Flow Model for

Thomas James O'Brien, Martin Welch

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. We have a community problem.Journal of bacteriology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. AnF1000Research · 2021
    Article
  12. UnravelingFrontiers in cellular and infection microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Thomas James O'BrienDepartment of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
Martin WelchDepartment of Biochemistry, University of Cambridge, Cambridge, United Kingdom.

Funding

National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/P001564/1
6 · The paper itself

Abstract

The airways of people with cystic fibrosis (CF) provide a nutrient-rich environment which favours colonisation by a variety of bacteria and fungi. Although the dominant pathogen associated with CF airway infections is

Indexed as

Candida albicansco-culturecontinuous-flowcystic fibrosisin vitroPseudomonas aeruginosaStaphylococcus aureus

Identifiers

PMID31824471
PMCPMC6883238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.